Gregory A. Poland American physician and vaccinologist
Poland, Gregory A.
Gregory Poland American physician and vaccinologist
VIAF ID: 315220373 (Personal)
Permalink: http://viaf.org/viaf/315220373
Preferred Forms
- 100 0 _ ‡a Gregory A. Poland ‡c American physician and vaccinologist
- 100 0 _ ‡a Gregory Poland ‡c American physician and vaccinologist
-
-
- 100 1 _ ‡a Poland, Gregory A.
- 100 1 _ ‡a Poland, Gregory A.
- 100 1 _ ‡a Poland, Gregory A.
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Immunizing healthcare workers : a practical approach | |
Pandemic : point-of-care pocket guide | |
Preserving Civility in Vaccine Policy Discourse: A Way Forward | |
Prevention of meningococcal disease: current use of polysaccharide and conjugate vaccines | |
The process of continuous journal improvement: new author guidelines for statistical and analytical reporting in VACCINE | |
Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals | |
The re-emergence of measles in developed countries: time to develop the next-generation measles vaccines? | |
Recursive Indirect-Paths Modularity (RIP-M) for Detecting Community Structure in RNA-Seq Co-expression Networks. | |
Replication of rubella vaccine population genetic studies: validation of HLA genotype and humoral response associations | |
Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22-23 March 2017. | |
Response surface methodology to determine optimal measles-specific cytokine responses in human peripheral blood mononuclear cells | |
RITAN: rapid integration of term annotation and network resources | |
The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity | |
The role of systems biology approaches in determining molecular signatures for the development of more effective vaccines | |
Room for improvement: immunizations for patients with monoclonal B-cell lymphocytosis or chronic lymphocytic leukemia. | |
Rubella virus-specific humoral immune responses and their interrelationships before and after a third dose of measles-mumps-rubella vaccine in women of childbearing age | |
Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant | |
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age | |
Sample sizes and negative studies in clinical vaccine research | |
SARS-CoV-2: a time for clear and immediate action | |
Score tests for association between traits and haplotypes when linkage phase is ambiguous | |
Seroprevalence and durability of rubella virus antibodies in a highly immunized population | |
Seroprevalence of antibody to varicella among Somali refugees | |
Severity of childhood asthma and human leukocyte antigens type | |
Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines | |
Smallpox vaccine: problems and prospects | |
Smallpox vaccines for biodefense | |
Smallpox vaccines: from first to second to third generation | |
The social, political, ethical, and economic aspects of biodefense vaccines | |
Soft truncation thresholding for gene set analysis of RNA-seq data: application to a vaccine study | |
Sophiology, vaccinology, and the healing professions - a warning from ancient Greece? | |
Standards for adult immunization practices | |
Statistical approach to estimate vaccinia-specific neutralizing antibody titers using a high-throughput assay | |
Statistical Methods for Testing Genetic Pleiotropy | |
Strategies to maximize influenza vaccine impact in older adults | |
Studies of twins in vaccinology | |
Submission of articles to Vaccine: a fast and fair peer review process | |
Szczepionka MMR i autyzm : nihilizm szczepionkowy a postmodernistyczna nauka | |
T-Cell epitope discovery for variola and vaccinia viruses | |
TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk | |
Taxa of the Nasal Microbiome Are Associated with Influenza-Specific IgA Response to Live Attenuated Influenza Vaccine | |
Testing vaccines in pediatric research subjects | |
Thirty years after smallpox: celebration and sobering thoughts | |
Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individuals | |
Transcriptomic signatures of cellular and humoral immune responses in older adults after seasonal influenza vaccination identified by data-driven clustering. | |
Trends affecting the future of vaccine development and delivery: the role of demographics, regulatory science, the anti-vaccine movement, and vaccinomics | |
Understanding the human immune system in the 21st century: the Human Immunology Project Consortium | |
The US smallpox vaccination program: a review of a large modern era smallpox vaccination implementation program | |
The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA) | |
Vaccinating donors for hematopoietic cell transplantation: A systematic review and future perspectives | |
Vaccinating health care workers against influenza: the ethical and legal rationale for a mandate | |
Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward | |
Vaccination of healthcare personnel in Europe: Update to current policies | |
Vaccinations | |
Vaccine education spectrum disorder: the importance of incorporating psychological and cognitive models into vaccine education | |
Vaccine history: the past as prelude to the future. | |
Vaccine immunogenetics: bedside to bench to population | |
Vaccines against influenza A (H5N1): evidence of progress | |
Vaccines against Lyme disease: What happened and what lessons can we learn? | |
Vaccinology in the third millennium: scientific and social challenges | |
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century | |
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections | |
Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology | |
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery? | |
Vacunas | |
Valuing influenza vaccine: medical, economic, and social benefits | |
Variability in Humoral Immunity to Measles Vaccine: New Developments | |
Vitamin D, leptin and impact on immune response to seasonal influenza A/H1N1 vaccine in older persons | |
We got broken first: on healing the healers. | |
Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination | |
Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases | |
Why not destroy the remaining smallpox virus stocks? | |
World Pneumonia Day: fighting pneumonia with safe and affordable vaccines | |
Writing a scientific paper-A brief guide for new investigators | |
Zika Vaccine Development: Current Status | |
Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection |